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Summary Histology features, the nuclear DNA content and prognosis of 42 female breast carcinomas found
in a physical examination based screening, 54 breast cancers found incidentally by medical personnel, and 274
breast cancers first suspected by the patient were compared. There was no significant difference in the
distribution by primary tumour size (P = 0.08) or histological type (P = 0.87) of breast cancer between the
screen-detected and 139 self-suspected cancers of women with similar mean age and living at the same time in
the same city, but the screen-detected carcinomas were better differentiated (P = 0.0002), and had less mitoses
(P =0.008), less tumour necrosis (P = 0.004) and DNA aneuploidy (P = 0.01), smaller S-phase fractions
(P = 0.009), less axillary metastases (P = 0.04), and had better outcome (P = 0.005) than self-suspected
carcinomas. These parameters did not differ significantly between the screen-detected and incidentally found
cancers, but incidental cancers had more often axillary metastases (P = 0.02). The results indicate that
screen-detected breast carcinomas have favourable biological features suggesting low degree of malignant
potential.
Breast carcinoma is usually first detected by the woman
herself, who notices a lump in her breast. A few carcinomas
are found incidentally by medical personnel, and an increas-
ing number is found in screening programs. Carcinomas
found in mammographic screening have been reported to be
of lower stage than cancers found in the control group
(Tabar et al., 1985; Andersson et al., 1988), and some trials
have indicated that mammographic screening reduces mor-
tality in breast cancer (Shapiro et al., 1983; Verbeek et al.,
1984; Tabar et al., 1985), whereas others have been less
conclusive (Andersson et al., 1988; UK Trial of Early Detec-
tion of Breast Cancer Group, 1988; Roberts et al., 1990).
Breast cancer found in screening or incidentally during
physical examination may form a special group of cancers
with a slow progression rate. There are currently little data
available to characterise screen-detected and incidentally
found breast carcinomas, which would be of value in treat-
ment planning. We have compared clinical presentation,
histology, DNA ploidy and prognosis of breast carcinomas
first suspected by the patient to those found incidentally by
the medical personnel, and to those found in a palpation
based mass screening.
Materials and methods
Patients
According to data from the Finnish Cancer Registry of
Finland 404 cases of breast cancer were diagnosed in Turku
in 1980 to 1984. After histological review, nine cases were
either benign tumours or some other type of cancer than
breast carcinoma. In two cases no biopsy had been taken and
in one case it was taken at autopsy, and in 22 cases either an
adequate histological sample or clinical data was lacking
leaving 370 patients for analysis, which is 94.1% of all
histologically diagnosed cases (n = 393) of breast carcinoma
in the area. The median follow-up time was 6 years (range,
from 4 to 9 years).
During .1980-84, 27,618 women were screened for cervical
cancer in Turku, South-Western Finland. Screening was
repeated with 5 years' intervals. In conjunction with this
screening palpation of the breasts was performed by an
experienced nurse, and subsequently suspicious or large
breasts, and those otherwise difficult to examine were
examined by mammography (n = 5,481, 20%).
According to data from hospital records, which were
reviewed, 42 (11%) of the 370 cases of breast cancer were
found in the palpation-based screening (referred to as
'screen-detected cancers'). All were found during the first
round of screening. In addition, 54 cancers (15%) had been
found incidentally during physical examination by physicians
(n = 49) or nurses (n = 5, referred to as 'incidentally found
cancers'). The rest of the tumours (n = 274, 74%) were first
noticed or suspected by the patient (tumour in the breast,
87%; pain or abnormal sensations in the breast, 9%; dis-
charge, 4%; dimpling of the skin, 4%; erythema or other
skin disorder, 3%; symptom or sign not known, 5%, referred
to as 'self-suspected cancers').
Clinical staging was done according to the postsurgical
UICC TNM classification (1987). The patients were usually
treated either with radical mastectomy or with mastectomy
and evacuation of the axillary lymph nodes (88%), but in 21
self-suspected cases and in 18 incidentally found cases simple
mastectomy had been performed. Two patients had partial
mastectomy only (both in the incidentally found group), and
two had biopsy only (both in the self-suspected group).
Post-operative radiotherapy was givenl to 198 patients (54%,
to 155 in the self-suspected group, 28
group, and to 15 in the incidentally f
cytostatic therapy with cyclophosphan
5-fluorouracil (CMF) was given to iC
screen-detected and nine self-suspected
fen to 29 (8%) patients (one screen-de
found and 23 self-suspected).
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ide, methotrexate and
(3%) patients (to one
) and adjuvant tamoxi-
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New haematoxylin-eosin and van Gieson stained slides were
prepared from each tissue block, and the original van Gieson
stained slides were reviewed. The histological typing and
grading of the tumours was done slightly modifying the
WHO classification, and the tumours were subsequently
classified into four types: (1) infiltrating ductal carcinomas
NOS (not otherwise specified, includes apocrine, mixed
mucinous, and atypical medullary types), (2) infiltrating
lobular carcinoma (includes variants), (3) other special types
(includes tubular, medullary, cribriform, papillary, metaplas-
tic and pure mucinous carcinomas), and (4) intraductal car-
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cinoma. Other histopathological features were evaluated
semiquantitatively as shown in Table II. In order to obtain
uniform histological classification all cases were classified by
one pathologist (S.T.).
DNA content analysis
Paraffin-embedded biopsies were processed for flow cytometry
from paraffin-embedded tissue as described earlier (Hedley et
al., 1983). DNA histograms were classified without
knowledge on the clinicopathological or survival data. Histo-
grams with a symmetrical or asymmetrical GO/GI peak (with
a 'shoulder') were classified as diploid. If 2 GO/GI peaks
were present, the histogram was classified as aneuploid, and
if more than two, as multiploid. A histogram with a GO/GI
peak at 4N and a G2/M peak at 8N was classified as
tetraploid. The S-phase fraction (SPF) was calcualted accord-
ing to the rectilinear method (Baisch et al., 1975; Camplejohn
et al., 1989). DNA ploidy was not determined in 29 of the
370 cases either due to lack of adequate amount of tissue
(n = 10, 3%) or uninterpretable or poor quality histogram
(n = 19, 5%). The mean coefficient of variation (CV) of the
diploid peaks was 6.0% (SD, 1.2%, range from 3.5 to 8.5%).
SPF could not be calculated in 55 cases (16%) either due to
small or overlapping peaks or presence of excessive cell
debris.
Statistical methods
Frequency tables were analysed with the chi-squared test or
Fisher's exact test. The chi-square test for trend was used for
ordinal variables. Comparison of non-normal distributions
was done with Mann-Whitney's U-test. Cumulative survival
was estimated with the product-limit method, and com-
parison of cumulative survival between groups was
performed with the log-rank test. Survival corrected for inter-
current deaths was used in statistical calculations, and
women who died from other causes than breast cancer were
withdrawn from the analysis at the date of death. Women
who died with disseminated breast cancer based on clinical or
autopsy evidence were considered to have died from breast
cancer. All P-values are two-tailed. Statistical calculations
were done with the BMDP computer program (BMDP Statis-
tical Software, Department of Biomathematics, University of
California, Los Angeles, CA).
Results
The mean age of the patients who self suspected breast
cancer was 62.2 ± 13.3 (SD, median, 64 years, range, from 29
to 88 years), which was different from that of the patients
with either screen-detected cancer (mean 52.9 ± 9.7 years,
median, 55 years, range, from 34 to 65 years, P <0.0001) or
incidentally found cancer (72.2 ± 12.3, median, 71.5, range,
from 29 to 97 years, P <0.0001).
Tumour size related parameters of the screen-detected
cancers are compared to 139 self-suspected cancers of women
within the same age range at the time of the diagnosis
(34-65 years, mean age 52.9 ± 7.9, P = 0.90, median, 53
years) and to incidentally found cancers in Table I. Patients
with screen-detected cancer tended to have a smaller primary
tumour than women who self suspected cancer (P = 0.08),
and had significantly less axillary nodal metastases than
either women with self-suspected cancer (P = 0.04) or women
with incidentally found cancer (P = 0.02), but there was no
difference in the frequency of distant metastases at the time
of the diagnosis.
When histological features of the screen-detected cancers
were compared with those of the self-suspected ones (Table
II), there was no difference in the distribution by histological
type, amount of stromal fibrosis, type of tumour margin
circumscription or extent ofintraductal growth of cancer, but
the screen-detected carcinomas were more often well-
differentiated (P = 0.0002), had less nuclear pleomorphism
(P = 0.0006), less tumour necrosis (P = 0.004), smaller
mitotic counts (P = 0.008), more stromal elastin (P = 0.02),
and had more extensive tubule formation (P = 0.02) than the
self-suspected ones. However, no difference in these histo-
logical parameters could be found between the screen-
detected and incidentally found carcinomas.
About half (47%) of the screen-detected carcinomas were
DNA diploid, whereas 74% of the self-suspected cancers
were DNA aneuploid (P = 0.01, Table III). Furthermore, the
mean SPF of the screen-detected carcinomas was 6.4% as
compared with 10.0% in the self-suspected group
(P = 0.009). These parameters did not differ between the
screen-detected and incidentally found carcinomas.
When the incidentally found carcinomas were compared
with all self-suspected cancers diagnosed during the same
time interval (n = 274), they had higher histological grade of
differentiation (P = 0.004), smaller mitotic counts (P = 0.01),
less nuclear pleomorphism (P = 0.02), smaller SPFs
(P = 0.001), and more stromal elastin (P = 0.01) and fibrosis
Table I Comparison of tumour size related parameters of 42 screen-detected, 139
self-suspected, and 54 incidentally found breast carcinomas
Screening- Self- Incidentally
detected suspected found
cancer cancer cancer
Parameter n (%) n (%) n (%) p,a P2
Primary tumour size
<2cm 25 (60) 61 (44) 25 (46)
>2cm or pT4 17 (40) 77 (56) 29 (54) 0.08 0.20
Axillary nodal statusb
pNO 31 (74) 75 (56) 16 (48)
pNl-3 11 (26) 58 (44) 17 (52) 0.04 0.02
Presence of distant
metastases at diagnosis
MO 41 (98) 129 (93) 51 (94)
Ml 1 (2) 10 (7) 3 (6) 0.46 0.63
Stageb
0 or I 22 (52) 42 (32) 10 (29)
II-IV 20 (48) 91 (68) 24 (71) 0.01 0.04
apI is the probability between screen-detected and self-suspected cancers of
women within the same age range (34-65 years) at the time of the diagnosis. P2 is
the probability between screen-detected and incidentally found cancers. bOnly
patients who had axillary nodal evacuation included.590 H. JOENSUU et al.
Table II Comparison of histological features of 42 screen-detected, 139
self-suspected, and 54 incidentally found breast carcinomas
Screening- Self- Incidentally
detected suspected found
cancer cancer cancer
Parameter n (%) n (%) n (%) pa P2
Histological grade
grade I
grade 2
grade 3
Nuclear pleomorphism
slight
moderate
severe
Tumour necrosisb
none
spotty/moderate/severe
Mitotic count/HPFC
rare
>2
Stromal elastin
none
some
moderate/severe
Tubule formation
extensive/moderate
slight/none
Extent of intraductal
growth
none
some/principal
growth pattern
Stromal fibrosis
some
moderate
none
Tumour margin
circumscription
definite
questionable
none
Histological type
ductal invasive
lobular
other special type/
intraductal cancer
18
20
4
13
25
4
(43)
(48)
(10)
(31)
(60)
(10)
31
53
55
18
78
43
(22)
(38)
(40)
(13)
(56)
(31)
26
19
9
19
26
9
(48)
(35)
(17)
(35)
(48)
(17)
37 (88) 90 (65) 45 (83)
5 (12) 49 (35) 9 (17)
26 (62) 54 (39) 32 (59)
16 (38) 85 (61) 22 (41)
18 (43)
10 (24)
14 (33)
75
46
18
(54)
(33)
(13)
17 (31)
13 (24)
24 (44)
18 (43) 33 (24) 23 (43)
24 (57) 106 (76) 31 (57)
13 (31) 61 (44) 23 (43)
29 (69) 78 (56) 31 (57)
12 (29)
12 (29)
17 (41)
10 (24)
9 (21)
23 (55)
29 (69)
7 (17)
6 (14)
49 (37)
45 (34)
40 (30)
24 (17)
45 (32)
70 (50)
97 (70)
24 (17)
18 (13)
13 (25)
13 (25)
27 (51)
7 (13)
16 (30)
31 (57)
37 (69)
11(20)
6 (11)
0.0002 0.90
0.0006 0.83
0.004 0.51
0.008 0.79
0.02 0.21
0.02 0.98
0.14 0.24
0.20 0.41
0.87 0.39
0.87 0.86
aP1 and P2 are as in Table I. bIntraductal comedo necrosis is not included.
CHPF = high power field. The number of mitoses counted was the average per one
high power field from ten fields (Leitz Othoplan, 40 x Plan objective).
Table III Comparison of DNA ploidy and S-phase fraction of 36 screen-detected,
127 self-suspected, and 49 incidentally found breast carcinomas
Screening- Self- Incidentally
detected suspected found
cancer cancer cancer
Parameter n (%) n (%) n (%) p1a p2
DNA ploidy
diploidb 17 (47) 33 (26) 21 (43)
nondiploid 19 (53) 94 (74) 28 (57) 0.01 0.69
S-phase fraction
mean± SD% 6.4 ± 5.4 10.0 ± 7.8 5.1 ± 4.8 0.009 0.21
95% confid. interval % 4.5 - 8.3 8.6 - 11.5 3.5 - 6.6
median % 4.0 7.0 3.5
range % 1-20 1-35 1-23
apI and P2 are as in Table I. bDiploid cases include also histograms with
asymmetrical GI peaks. Nondiploid histograms include DNA aneuploid,
tetraploid and multiploid cases.SCREEN-DETECTED AND INCIDENTAL BREAST CANCER 591
(P = 0.03), but there was no significant difference in histo-
logical type of the primary tumour (P = 0.68), type of
tumour margin circumscription (P = 0.22), degree of tubule
formation (P = 0.12), tumour necrosis (P = 0.07), primary
tumour size (pT, P = 0.36), frequency of axillary nodal
involvement (pN, P = 0.64), frequency of distant metastases
at the time of the diagnosis (P = 0.77), or DNA ploidy
(P = 0.10).
The 5-year survival rates corrected for intercurrent deaths
of women with screen-detected cancer, incidentally found
cancer, self-suspected cancer (n = 274), and with self-
suspected cancer and aged 34 to 65 years at the time of the
diagnosis were 90%, 79%, 73% and 70%, respectively. The
survival rate corrected for intercurrent deaths of women with
screen-detected carcinoma was superior if compared to the
139 women with self-suspected cancer age 34 to 65 years at
the time ofthe diagnosis (P = 0.005), or with all women with
self-suspected cancer (n = 274, P = 0.009), and tended to be
better if compared to that of women with incidentally found
cancer (P = 0.09). The outcome of women with incidentally
found cancer was not significantly different from that of
women with self-suspected cancer (n = 274, P = 0.58).
Discussion
The results indicate that breast carcinomas found in screen-
ing differ in many respects from those found outside screen-
ing in women within the same age range. Screen-detected
cancers had less often axillary metastases and better final
outcome, and they also had several features suggesting low
malignant potential, such as a small proliferation rate (small
SPF and low mitotic counts), low histological and nuclear
grade, and absence of tumour necrosis.
Cancers may become less differentiated with increasing age
of cancer as a result from malignant progression. Therefore,
if small carcinomas found in screening are compared with
controls that are larger in size, the latter may be found to be
associated with more aggressive histological and cytometric
features, although no difference would have existed if
tumours of similar biological age had been compared. In the
present series the screen-detected group had more small
(<2 cm) cancers than the control group (60% vs 44%), but
the difference was not significant (P = 0.08). If the data are
adjusted to the primary tumour size ( 2 cm vs >2 cm), and
the interactions between screen-detected and self-suspected
cancers, and the various histological parameters shown in
Table II are analysed with a loglinear model (Fienberg,
1977), screen-detected cancers are still better differentiated
(P = 0.001), have less nuclear pleomorphism (P = 0.006), less
tumour necrosis (P = 0.008), lower mitotic counts (P = 0.004),
more stromal elastin (P = 0.009), and more tubule formation
(P = 0.04) than the control cancers of the women with a
similar mean age. Similarly, if the size of the SPF is com-
pared between the two groups adjusting to the primary
tumour size by a two-way analysis of variance, a significant
(P = 0.02) difference still exists.
The basic screening method was physical examination, and
only 20% of the women were subsequently investigated by
mammography. Results well in accordance with the present
ones have been reported from a mammography based series
(Kallioniemi et al., 1988), where 37 breast carcinomas found
in mammography screening in 1984-87 were compared with
60 breast cancers detected clinically in two university hos-
pitals in 1975-82. In this study DNA aneuploidy was
observed in 46% of screen-detected and in 68% of clinically
detected cancers, and the median SPF was significantly lower
(3.5%) in screen-detected cancer than in the clinical controls
(9.6%), which were, however, larger in size than the screen-
detected cancers. Using static cytofluorometry Hatschek et al.
(1989) found significantly less DNA aneuploidy in car-
cinomas detected at the second or the third mammography
screening round than in controls, but found the mean SPFs
to be similar in both groups.
Judging from autopsy studies, in situ breast carcinoma
occurs frequently in the general population in young and
middle-aged women. Nielsen et al. (1987) found either ductal
carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS)
or both DCIS and LCIS in 18% of 110 consecutive medico-
legal autopsies in 20 to 54-years-old Danish women, and 2%
of the women had invasive breast cancer. Moreover, only
45% of these lesions could be identified in specimen mam-
mography. Hence, undiagnosed premalignant and malignant
lesions of the breast with low malignant potential may be
more common than previously thought, and screening may
detect cancers that otherwise would not be diagnosed during
the life-time of the woman, thus diminishing the life-saving
effect of screening.
Incidentally found breast cancers are expected to resemble
cancers found in palpation based screening, and, indeed,
there was no significant difference present in any of the
histological parameters investigated, the primary tumour size,
size of the SPF, or DNA ploidy between the screen-detected
and incidentally found cancers. However, the latter had more
often axillary nodal metastases (P = 0.02) and tended to
have inferior outcome (P = 0.09). The greater metastasis rate
ofincidentally found cancers remains to be explained, but the
patients with incidentally found carcinoma were significantly
older, and it has been suggested that the prevalence of meta-
static disease increases or host resistance decreases with in-
creasing age (Adami et al., 1986).
Women with screen-detected breast cancer had more
favourable survival than those with self-suspected cancer.
The lower malignant potential of screen-detected cancers
(length bias) is likely to explain this at least partially, but
other factors also count. Even if screening had no effect on
the clinical course of breast cancer, the time between the
diagnosis and death is automatically lengthened in screen-
detected cases, because the diagnosis is made at an earlier
stage of the course of the disease (lead-time bias). Further-
more, who attend screening may be health-conscious, whereas
the self-suspected group is likely to contain women who
delay their presentation for months or years, and may not
take optimal care of their health after the diagnosis has been
made (selection bias).
In conclusion, breast carcinomas found in palpation based
screening were associated with more favourable prognosis
than self-suspected carcinomas, but this is unlikely to be
explained by their earlier detection alone. Considerable
differences were present in several parameters associated with
the degree the malignant potential ofcancer, such as grade of
differentiation, proliferation rate and metastasis rate. Inciden-
tally found breast cancers were histologically similar to the
screen-detected ones, and usually had also a slow prolifera-
tion rate, but the metastasis rate was higher. The more
favourable biological features of screen-detected breast
cancer as compared with self-detected cancer may explain
why only a modest reduction in breast cancer mortality has
been achieved by screening in a few recent randomised trials.
This work was supported by grants from Cancer Society of Finland
and Turku University Foundation. The authors thank the staff of
the Finnish Cancer Registry for co-operation.
References
ADAMI, H.-O., MALKER, B., HOLMBERG, L., PERSSON, I. & STONE,
B. (1986). The relation between survival and age at diagnosis in
breast cancer. N. Engi. J. Med., 315, 559.
ANDERSSON, I., ASPERGREN, K., JANZON, L. & 6 others (1988).
Mammographic screening and mortality from breast cancer: the
Malmo mammographic screening trial. Br. Med. J., 297, 943.592 H. JOENSUU et al.
BAISCH,. H., GOHDE, W. & LINDEN, W.A. (1975). Analysis of PCP-
data to determine the fraction of cells in the various phases of the
cell cycle. Rad. Environm. Biophys., 12, 31.
CAMPLEJOHN, R.S., MACARTNEY, J.C. & MORRIS, R.W. (1989).
Measurement of S-phase fractions in lymphoid tissue comparing
fresh versus paraffin-embedded tissue and 4',6'-diamino-2
phenylindole dihydrochloride versus propidium iodide staining.
Cytometry, 10, 410.
FIENBERG, S.E. (1977). The Analysis of Cross-Classifed Categorical
Data. Cambridge: Massachusetts, MIT Press.
HATSCHEK, T., FAGERBERG, G., STAL, 0. & 4 others (1989).
Cytometric characterization and clinical course of breast cancer
diagnosed in a population based screening program. Cancer, 64,
1074.
HEDLEY, D.W., FRIEDLANDER, M.L., TAYLOR, I.W., RUGG, C.A. &
MUSGROVE, E.A. (1983). Method for analysis of cellular DNA
content of paraffin-embedded pathological material using flow
cytometry. J. Histochem. Cytochem., 31, 1333.
KALLIONIEMI, O.-P., KARKKAINEN, A., AUVINEN, O., MATTILA, J.,
KOIVULA, T. & HAKAMA, M. (1988). DNA flow cytometric
analysis indicates that many breast cancers detected in the first
round of mammographic screening have a low malignant poten-
tial. Int. J. Cancer., 42, 697.
NIELSEN, M., THOMSEN, J.L., PRIMDAHL, S., DYREBORG, U. &
ANDERSEN, J.A. (1987). Breast cancer and atypia among young
and middle-aged women: a study of 110 medicolegal autopsies.
Br. J. Cancer, 56, 814.
ROBERTS, M.M., ALEXANDER, F.E., ANDERSON, T.J. & 9 others
(1990). Edinburgh trial of screening for breast cancer: mortality
at seven years. Lancet, i, 241.
SHAPIRO, S., VENET, W., STRAX, P., VENET, L. & ROESER, R. (1985).
Selection, follow-up, and analysis in the health insurance plan
study: a randomised trial with breast cancer screening. Natl
Cancer Inst. Monogr., 67, 65.
TABAR, L., FAGERBERG, C.J.G., GAD, A. & 6 others (1985). Reduc-
tion in mortality from breast cancer after mass screening with
mammography. Lancet, i, 829.
UK TRIAL OF EARLY DETECTION OF BREAST CANCER GROUP
(1988). First results on mortality reduction in the UK trial of
early detection of breast cancer. Lancet, fi, 411.
VERBEEK, A.L.M., HENDRIKS, J.H.C.L., HOLLAND, R., MRAVUNAC,
M., STURMANS, F. & DAY, N.E. (1984). Reduction of breast
cancer mortality through mass screening with modem mammo-
graphy. Lancet, i, 1222.